Change from inhibition to stimulation by levan of AKR lymphoma following serial transfers

J. Leibovici, S. Hoenig, Y. Stark, S. Kopel, M. Wolman

Research output: Contribution to journalArticlepeer-review

Abstract

A progressive increase in malignancy following serial passages of AKR lymphoma is often accompanied by loss in sensitivity to the antitumor agent, levan, In further transfers, stimulation of tumor growth, instead of inhibition, is sometimes observed. It is proposed that the shift from inhibition to stimulation of tumor growth by the immunomodulator levan may be due to a change during tumor progression in the sensitivity of the tumor cells to the reported dual effect of macrophages, inhibitory or stimulatory, on tumor growth.

Original languageEnglish
Pages (from-to)219-224
Number of pages6
JournalExperimental Cell Biology
Volume52
Issue number4
DOIs
StatePublished - 1984

Fingerprint

Dive into the research topics of 'Change from inhibition to stimulation by levan of AKR lymphoma following serial transfers'. Together they form a unique fingerprint.

Cite this